Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001193125-26-057168
Filing Date
2026-02-18
Accepted
2026-02-18 16:31:03
Documents
1
Period of Report
2026-02-13

Document Format Files

Seq Description Document Type Size
1 4 ownership.html 4  
1 4 ownership.xml 4 4349
  Complete submission text file 0001193125-26-057168.txt   5879
Mailing Address C/O CORBUS PHARMACEUTICALS HOLDINGS, INC 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address
Moran Sean F. (Reporting) CIK: 0001451495 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-37348 | Film No.: 26648943

Mailing Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062
Business Address 500 RIVER RIDGE DRIVE NORWOOD MA 02062 617-963-0103
Corbus Pharmaceuticals Holdings, Inc. (Issuer) CIK: 0001595097 (see all company filings)

EIN.: 464348039 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)